Mgc Pharmaceuticals Stock Current Asset
MGCLFDelisted Stock | USD 0.21 0.00 0.00% |
MGC Pharmaceuticals fundamentals help investors to digest information that contributes to MGC Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of MGC OTC Stock. The fundamental analysis module provides a way to measure MGC Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MGC Pharmaceuticals otc stock.
MGC |
MGC Pharmaceuticals OTC Stock Current Asset Analysis
MGC Pharmaceuticals' Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
CompetitionIn accordance with the recently published financial statements, MGC Pharmaceuticals has a Current Asset of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The current asset for all United States stocks is 100.0% higher than that of the company.
MGC Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MGC Pharmaceuticals' direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of MGC Pharmaceuticals could also be used in its relative valuation, which is a method of valuing MGC Pharmaceuticals by comparing valuation metrics of similar companies.MGC Pharmaceuticals is currently under evaluation in current asset category among its peers.
MGC Fundamentals
Return On Equity | -2.19 | |||
Return On Asset | -0.45 | |||
Operating Margin | (3.28) % | |||
Current Valuation | 24.97 M | |||
Shares Outstanding | 2.87 B | |||
Shares Owned By Insiders | 9.10 % | |||
Shares Owned By Institutions | 6.12 % | |||
Price To Book | 5.69 X | |||
Price To Sales | 5.81 X | |||
Revenue | 4.65 M | |||
Gross Profit | 562.87 K | |||
EBITDA | (16.44 M) | |||
Net Income | (20.35 M) | |||
Cash And Equivalents | 1.89 M | |||
Total Debt | 4.35 M | |||
Debt To Equity | 0.84 % | |||
Current Ratio | 0.84 X | |||
Book Value Per Share | 0 X | |||
Cash Flow From Operations | (12.16 M) | |||
Earnings Per Share | (0.01) X | |||
Number Of Employees | 16 | |||
Beta | 1.23 | |||
Market Capitalization | 17.2 M | |||
Total Asset | 22.6 M | |||
Z Score | 1.8 | |||
Net Asset | 22.6 M |
About MGC Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MGC Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MGC Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MGC Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in MGC OTC Stock
If you are still planning to invest in MGC Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MGC Pharmaceuticals' history and understand the potential risks before investing.
Transaction History View history of all your transactions and understand their impact on performance | |
CEOs Directory Screen CEOs from public companies around the world | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |